Related Experiment Video
Updated: Aug 17, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Growth of Staphylococcus epidermidis in anaesthetic resuscitative drugs: implications for potential contamination
1Departments of Anaesthesia and Microbiology, The Townsville Hospital, Townsville, Queensland.
Abstract:
This controlled laboratory study investigated the survival of Staphylococcus epidermidis (S. epidermidis) over a 24 hour period in four commonly drawn-up anaesthetic resuscitative drugs: suxamethonium, atropine, metaraminol and ephedrine. These drugs were prepared in typical therapeutic concentrations and then inoculated with S. epidermidis. Samples of the inoculated drug preparations were cultured on horse blood agar plates at 0, 2, 6, 12 and 24 hourly intervals and incubated for 24 hours. Colony counts were performed at the end of the incubation period. Suxamethonium, atropine and metaraminol all showed an inhibitory effect on colony counts within the first six hours. There was a more gradual decline of colony counts over a 24 hour period in the ephedrine solution. This decline was similar to that occurring in the normal saline. It is concluded that suxamethonium, atropine and metaraminol do not support the survival of the common skin contaminant, S. epidermidis over a 24 hour period.
Insights
Suxamethonium, atropine, and metaraminol inhibit Staphylococcus epidermidis survival in anesthetic drugs. Ephedrine showed a slower decline, similar to saline, indicating limited antimicrobial properties against this common contaminant.
Area of Science:
- Anesthesiology
- Microbiology
- Pharmaceutical Science
Background:
- Healthcare-associated infections are a significant concern.
- Contamination of injectable medications poses a risk.
- Staphylococcus epidermidis is a common skin bacterium and potential contaminant.
Purpose of the Study:
- To evaluate the in vitro survival of Staphylococcus epidermidis in commonly used anesthetic resuscitative drugs.
- To determine the antimicrobial properties of suxamethonium, atropine, metaraminol, and ephedrine against S. epidermidis.
Main Methods:
- Controlled laboratory study.
- Inoculation of four anesthetic drugs (suxamethonium, atropine, metaraminol, ephedrine) with S. epidermidis.
- Culture and colony counts on horse blood agar at 0, 2, 6, 12, and 24 hours.
Main Results:
- Suxamethonium, atropine, and metaraminol demonstrated significant inhibition of S. epidermidis colony counts within six hours.
- Ephedrine exhibited a gradual decline in S. epidermidis counts over 24 hours, comparable to normal saline.
- These findings suggest limited support for S. epidermidis survival in the tested drugs.
Conclusions:
- Suxamethonium, atropine, and metaraminol do not support the survival of Staphylococcus epidermidis over a 24-hour period.
- Ephedrine shows minimal antimicrobial activity against S. epidermidis.
- These results have implications for medication handling and infection control in clinical settings.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Asepsis
Key Techniques in Microbiology